$CXDO

Crexendo (NASDAQ:CXDO) CFO Ron Vincent Sells 29,000 Shares of Stock

Crexendo CFO Ron Vincent sold 29,000 shares of CXDO on May 22 at an average $9.77, raising about $283,330, according to an SEC filing. After the sale, he directly owned 117,087 shares (~$1.14M), down 19.85%. The article also notes additional sales in May and that Crexendo reported May 5 EPS of $0.10 vs $0.08 consensus on revenue of $20.71M.

Original reporting
Published May 28, 2026, 10:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 28, 2026, 11:19 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Crexendo (NASDAQ:CXDO) CFO Ron Vincent Sells 29,000 Shares of Stock — source image
Decision brief

The 30-second read

$CXDONeutralMed
01

Why it matters

The immediate tradable element is the insider-selling signal (sentiment/positioning) layered on top of a recent earnings beat and modestly bullish analyst targets.

02

Market read

CXDO receives a near-term sentiment check from repeated insider selling, but the article lacks a new fundamental shock; the next driver is likely subsequent filings/catalysts after the May earnings print.

03

What to watch

The article doesn’t specify whether sales were pre-arranged (10b5-1) or for diversification; traders should check the SEC filing details and whether volume/price moved on the sale dates.

Relevance 7/10Novelty 6/10Timing: today/this week as traders digest the latest Form 4 insider-sale disclosure

Background

The article summarizes multiple insider share sales by Crexendo CFO Ron Vincent disclosed via SEC filings, alongside recent earnings and analyst rating/target context.

Company-level read

Ticker impact

$CXDONeutralMedium confidence
Context

Crexendo CFO Ron Vincent sold 29,000 shares (plus multiple other sales in May), reducing insider ownership by ~19.85%.

Expected impact

Short-term downside risk to sentiment is modest; follow-through depends on whether selling continues and how price reacts to the next catalyst.

Evidence & confidence

The disclosure is a Form 4-style insider transaction with multiple sales clustered in May, which can pressure sentiment, but it is not tied to a new company-specific event (e.g., guidance change, deal, or investigation).

Market effects

Limited sector read-through; this is company-specific insider selling within cloud communications/UCaaS.

None indicated beyond US small/mid-cap sentiment.

None indicated.

Counterpoint

CFO selling can be routine (taxes/plan-based) and doesn’t necessarily reflect deteriorating fundamentals, especially with the stock near recent highs.

Key entities

  • Crexendo

    NASDAQ-listed cloud communications provider; subject of CFO insider-sale disclosures and recent earnings beat.

  • Ron Vincent

    Crexendo CFO; sold shares on May 22 and several additional dates in May per SEC disclosures.

Related articles

$CXDOMed

Crexendo, Inc. (CXDO): Results of Operations and Financial Condition

Crexendo, Inc. (CXDO) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 cxdo_ex991.htm PRESS RELEASE cxdo_ex991.htm EXHIBIT 99.1 Crexendo Announces Strong Second Quarter 2026 Results PHOENIX, AZ / ACCESSWIRE / August 4, 2026 / Crexendo, Inc. (NASDAQ: CXDO), an award-winning software technology company that is a premier provider of cloud com

$PAYMed

10 Best Growth Stocks to Buy with Low P/E Ratios

The article screens for growth stocks with average revenue growth of at least 30% over five years and forward P/E below 25, then ranks them by forward P/E. It highlights Paymentus (PAY) with forward P/E 22.92 and 31.72% revenue growth; Wedbush raised its target to $36 and Baird to $34 after strong Q1 results and raised 2026 guidance. It also cites Crexendo (CXDO) with forward P/E 18.73 and 32.99% growth; Needham raised its target to $12 after strong Q1 organic telecom growth and deal wins.

$ACIMed

Albertsons recalls ready-to-eat items in multiple states amid salmonella-linked jalapeño investigation

Albertsons Companies said it is voluntarily recalling four ready-to-eat products containing jalapeños supplied by Taylor Farms, including items sold at Randalls in Texas. The recall followed a supplier recall tied to an ongoing federal investigation and an FDA probe of a Salmonella Javiana outbreak. FDA reported 345 illnesses in 27 states, 36 hospitalizations, no deaths.

$CMGMed

Salmonella outbreak from Mexican jalapeños reported in 27 U.S. states

U.S. health authorities are investigating a Salmonella outbreak linked to Mexican jalapeño peppers. The CDC and FDA say 345 people are ill across 27 states, with 36 hospitalizations and no deaths. The supplier, Coast Citrus Distributors, recalled peppers sent to restaurants including Chipotle and QDOBA. Chipotle removed jalapeños from some outlets and shares fell over 8% on Aug. 4.